Hospices Civils de Lyon: Lymphoma trials
The registry lists 16 Lymphoma studies with Hospices Civils de Lyon as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 1No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Transplantation After Complete Response In Patients With T-cell LymphomaRecruitingNCT05444712Not applicable
- REal World Data in LYmphoma and Survival in AdultsRecruitingNCT03869619
- BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.Active, not recruitingNCT06424379
- Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T CellsStatus unknownNCT05532761
- Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With UveitisCompletedNCT05388838Not applicable
- Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)Status unknownNCT03859544
- Refractory Diffuse Large B-cell LymphomaCompletedNCT03664336
- Anti-PD-1 and Chemotherapy for R/R Hodgkin LymphomaCompletedNCT03664323
- Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab EraCompletedNCT03663894
- Constitutional Genetics in Follicular LymphomaStatus unknownNCT03234140
- Mediastinal Grey Zone Lymphoma From the LYSACompletedNCT03037177
- CD180 Overexpression in Follicular LymphomaCompletedNCT02978898
- Causes of Death in Follicular Lymphoma: a Single Center Retrospective AnalysisCompletedNCT02951871
- Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT02520895
- A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in LymphomaCompletedNCT00498043Phase 2
- Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised StudyStatus unknownNCT00169598Not applicable